SEI Investments’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

SEI Investments’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8	Closed	–	–	3719
2018 Q2	$0	Buy	+8	New	+$190	﹤0.01%	3901

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SEI Investments's AVEO Position: Q3 2018 in Review

SEI Investments sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2018, closing a stake of 8 shares.

SEI Investments first reported a position in AVEO in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 101 funds tracked by Wall St. Rank hold AVEO as of Q3 2018.

SEI Investments reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
SEI Investments sold 8 AVEO Pharmaceuticals, Inc. shares in Q3 2018.
SEI Investments first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 1 quarter.
SEI Investments's AVEO Pharmaceuticals, Inc. position peaked at $0 in Q2 2018.
101 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2018.

Based on SEI Investments's 13F filing for Q3 2018, filed 8 Nov 2018.